Kimryn Rathmell: Celebrating Krzysztof Mrózek’s Outstanding Achievement in Leukemia Research
Kimryn Rathmell and Krzysztof Mrózek/LinkedIn

Kimryn Rathmell: Celebrating Krzysztof Mrózek’s Outstanding Achievement in Leukemia Research

Kimryn Rathmell, Chief Executive Officer of Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, shared on LinkedIn:

“I am thrilled to share the legacy of groundbreaking leukemia research from The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, which has earned a new international recognition.

Krzysztof Mrózek, a research scientist in Ohio State’s Division of Hematology and the Clara D. Bloomfield Center for Leukemia Outcomes Research, has been elected a Foreign Member of the Polish Academy of Sciences, the highest scientific honor bestowed by Poland.

This distinguished recognition reflects Dr. Mrózek’s outstanding career scientific achievements, his contributions to advancing leukemia research and his commitment to international scientific collaboration. Dr. Mrózek’s work has helped expand our understanding of the genetic and molecular factors that influence leukemia diagnosis, prognosis and treatment.

We are proud to celebrate this remarkable achievement and look forward to honoring Dr. Mrózek as he receives his membership diploma in Warsaw later this year.

Please help me congratulate Dr. Mrózek on this outstanding achievement!”

Kimryn Rathmell: Celebrating Krzysztof Mrózek’s Outstanding Achievement in Leukemia Research

Other articles featuring Kimryn Rathmell on OncoDaily.